PATHOLOGY CENTER FOR LYMPHOMA CLINICAL STUDIES

淋巴瘤临床研究病理中心

• 批准号: 3556426
• 负责人: HENRY RAPPAPORT
• 金额: $ 25.22万
• 依托单位: CITY OF HOPE NATIONAL MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1976
• 资助国家: 美国
• 起止时间: 1976-03-01 至 1988-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556426
• 关键词: Hodgkin's disease; cancer information system; cancer registry /resource; combination cancer therapy; cooperative study; cytodiagnosis; histopathology; human subject; human therapy evaluation; lymphoma; mycosis fungoides lymphoma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer radiation therapy

The Repository Center and the Pathology Panel for Lymphoma Clinical Studies are headed by pathologists who have specialized in the diagnosis and study of neoplastic diseases of the lymphoid system and are making a joint effort to improve and refine the criteria for diagnosis and classification of these neoplastic diseases, thus assuring the validity of the therapeutic results obtained by their clinical colleagues engaged in therapeutic clinical studies. The Pathology Panel and the Repository Center for Lymphoma Clinical Studies have five major objectives which are closely interrelated: (1) Maintenance of a Pathology Repository Center and Regional Centers for lymphoma clinical studies conducted by NIH supported cooperative groups and of a pathology reference file for clinical study of Hodgkin's disease; (2) Testing the Reproducibility and clinical relevance of the New Working Formulation of non-Hodgkin's lymphoma for clinical usage recommended by an expert international panel; (3) Education of pathologists who are responsible for entry diagnoses of the cooperative protocol studies in an effort to increase the quality of their diagnoses and thereby minimize entry of any patients into protocols to which they do not belong; (4) Furnishing research support for clinical cooperative groups engaged in lymphoma clinical studies; (5) Utilizing the histopathologic material stored in the Repository Center for collaborative research projects closely related to the primary aim. In addition, the Pathology Panel is seeking to incorporate other ancillary methods into a multidisciplinary approach for the diagnosis and classification of malignant lymphomas.

淋巴瘤临床研究储存中心和病理学小组 由专门从事诊断和研究的病理学家领导 淋巴系统肿瘤性疾病的研究并正在共同努力 改进和细化诊断和分类标准 这些肿瘤性疾病，从而确保治疗的有效性 从事治疗的临床同事获得的结果 临床研究。 病理学小组和储存中心 淋巴瘤临床研究有五个主要目标，这些目标密切相关 相互关联的：（1）病理学储存中心的维护和 NIH 支持的区域淋巴瘤临床研究中心 合作小组和用于临床研究的病理学参考文件 霍奇金病； (2) 测试重现性和临床相关性 临床使用非霍奇金淋巴瘤新工作制剂的研究 由国际专家小组推荐； (3) 病理学家教育 谁负责合作方案研究的进入诊断 努力提高诊断质量，从而 尽量减少任何患者加入他们不属于的协议； （四）为从事临床合作的团体提供研究支持 淋巴瘤临床研究； (5)利用组织病理学材料 存储在存储中心，用于密切合作研究项目 与主要目标相关。 此外，病理学小组正在寻求 将其他辅助方法纳入多学科方法中 恶性淋巴瘤的诊断和分类。